•
Mar 31, 2023

Sanara MedTech Q1 2023 Earnings Report

Sanara MedTech reported record revenue driven by increased facilities, higher average sales per facility, and expanded product lines.

Key Takeaways

Sanara MedTech Inc. announced record revenue for the first quarter of 2023, with March being the highest sales month in the company's history. The growth was driven by an increased number of facilities selling their products, higher average sales per facility, and the promotion of expanded product lines. The company also submitted its Precision Healing Multispectral Imager for 510(k) clearance and received 510(k) clearance for BIASURGEâ„¢ Advanced Surgical Solution, with commercial launch preparation underway for late 2023.

Achieved record revenue in Q1 2023.

March marked the highest sales month in the Company’s history.

Revenue growth driven by increased facilities, higher average sales per facility, and expanded product lines.

Received 510(k) clearance for BIASURGEâ„¢ Advanced Surgical Solution and preparing for commercial launch in late 2023.

Total Revenue
$15.5M
Previous year: $7.81M
+98.7%
EPS
-$0.14
Previous year: -$0.41
-65.9%
Gross Profit
$13.4M
Previous year: $7.01M
+91.2%
Cash and Equivalents
$7.29M
Previous year: $16.1M
-54.9%
Free Cash Flow
-$1.77M
Previous year: -$2.16M
-18.0%
Total Assets
$60M
Previous year: $33.9M
+76.7%

Sanara MedTech

Sanara MedTech

Forward Guidance

The company anticipates resolution of the supply issues in the second half of 2023.